Abstract:Objectives: Randomized controlled trials (RCTs) with repeatedly measured continuous variables as primary outcomes are common. Although statistical methodologies for calculating sample sizes in such trials have been extensively investigated, their practical application remains unclear. This study aims to provide an overview of sample size calculation methods for different research questions (e.g., key time point treatment effect, treatment effect change over time) and evaluate the adequacy of current practices in trial design. Study Design and Setting: We conducted a comprehensive search of PubMed to identify RCTs published in core journals in 2019 that utilized repeatedly measured continuous variables as their primary outcomes. Data were extracted using a predefined questionnaire including general study characteristics, primary outcomes, detailed sample size calculation methods, and methods for analyzing the primary outcome. We re-estimated the sample size for trials that provided all relevant parameters. Results: A total of 168 RCTs were included, with a median of four repeated measurements (interquartile range 3e6) per outcome. In 48 (28.6%) trials, the primary outcome used for sample size calculation differed from the one used in defining the primary outcomes. There were 90 (53.6%) trials exhibited inconsistencies between the hypotheses specified for sample size calculation and those specified for primary analysis. The statistical methods used for sample size calculation in 158 (94.0%) trials did not align with those used for primary analysis. Additionally, only 6 (3.6%) trials accounted for the number of repeated measurements, and 7 (4.2%) trials considered the correlation among these measurements when calculating the sample size. Furthermore, of the 128 (76.2%) trials that considered loss to follow-up, 33 (25.8%) used an incorrect formula (i.e., N*(1+lose rate) for sample size adjustment. In 53 (49.5%) out of 107 trials, the re-estimated sample size was larger than the reported sample size. Conclusion: The practice of sample size calculation for RCTs with repeatedly measured continuous variables as primary outcomes displayed significant deficiencies, with a notable proportion of trials failed to report essential parameters about repeated measurement required for sample size calculation. Our findings highlight the urgent need to use optimal sample size methods that align with the research hypothesis, primary analysis method, and the form of the primary outcome. (c) 2023 Elsevier Inc. All rights reserved.

Sample Size Calculations for Randomized Controlled Trials with Repeatedly Measured Continuous Variables As Primary Outcomes Need Improvements: a Cross-Sectional Study.

Analyses of repeatedly measured continuous outcomes in randomized controlled trials needed substantial improvements

Missing data were poorly reported and handled in randomized controlled trials with repeatedly measured continuous outcomes: a cross-sectional survey

The optimal pre-post allocation for randomized clinical trials

Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable

How many repeated measures in repeated measures designs? Statistical issues for comparative trials

Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial

Methods for sample size determination in cluster randomized trials

Sample size calculation for recurrent event data with additive rates models

Use of statistical methods among acupuncture randomized controlled trials was far from satisfactory

Sample Size Estimation in Clinical Research

Sample size considerations for matched‐pair cluster randomization design with incomplete observations of binary outcomes

Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations

Smoothing Corrections for Improving Sample Size Recalculation Rules in Adaptive Group Sequential Study Designs

Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data

Sample size calculation in clinical trial using R

Simplification or simulation: Power calculation in clinical trials

Measurement error in continuous endpoints in randomised trials: problems and solutions

Sample size considerations for stratified cluster randomization design with binary outcomes and varying cluster size

Sample size re-estimation in crossover trials: application to the AIM HY-INFORM study

Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes